Lung/Head &Neck Cancer Program

The Lung/Head & Neck Cancer Program includes investigators interested in tumors of the respiratory tract, including lung, head and neck malignancy. Focus areas include:

• prevention
• biomarkers and early detection
• genetics and tumor biology
• experimental therapeutics.

Scientific Goal

To decrease the incidence and motality of thoracic and head and neck cancers.

Program Goal

• To increase productive interactions between individual basic science members, translational scientists and clinical scientists
• To recruit new investigators who will interact creatively with the Thoracic Oncology Program

Program Activities

• Career Development Grant
• Pilot Project Grants
• Monthly Seminar Series

Program Members

The Thoracic Oncology Program is comprised of 51 members (35 Full and 16 Associate). Six of the Full Members also hold joint membership in the Developmental Therapeutics, Carcinogenesis/Chemoprevention or Cancer Cell Biology Programs. Member interests include smoking cessation, biomarkers and early detection, epithelial carcinogenesis, tumor genetics and biology, chemoprevention and therapy. View member list.

Publications

The Lung, Head & Neck Program produced a total of 85 cancer-related publications from October 1, 2008 through September 30, 2009. Of these, 25 (29%) were inter-programmatic publications; 9 (11%) were intra-programmatic publications; and 19 (22%) were inter-/intra-programmatic. Thus, there were 53 (62%) collaborative publications.  View publications (pdf)